Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease fontaine stage IV

Vasa - Journal of Vascular Diseases

Volumn 27, Issue 1, 1998, Pages 15-19

  Beischer, W ^b   Dembski, J C ^b   Gruss, J D ^b   Hofgartner F ^b   Hosch, A ^b   Horsch, S ^b   Kuhlmann, H W ^b   Loose, D A ^b   Mietaschk, A ^b   Schwilden, E D ^b   Spengel, F ^b   Spitzer, W ^b   Staben, P ^b   Stallkamp, B ^b   Sturzebecher C S ^a   Tokhi, M ^b   Von Bilderling, P ^b  

^a BAYER PHARMA AG   (Germany)

^b NONE

Author keywords

Dose response; Efficacy; Iloprost; PAOD; Side effects

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIAC AGENT; CORONARY VASODILATING AGENT; ILOPROST; PROSTAGLANDIN E1; PROSTANOID;

AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FLUSHING; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG AMPUTATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MICROCIRCULATION; MORTALITY; NAUSEA; PAIN ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SKIN BLOOD FLOW; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ILOPROST; INFUSIONS, INTRAVENOUS; ISCHEMIA; LEG; MALE; MICROCIRCULATION; MIDDLE AGED; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 6844255233     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Altstaedt HO, Berzewski B, Breddin HK et al. Treatment of patients with periopheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 1993; 43: 573-8.
2. Balzer K, Rogatti W, Ruttgerodt K. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV. Vasa Suppl 1989; 28: 31-8.
3. Balzer K, Bechara G, Bisler H et al. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease - a double blind placebo controlled trial with iloprost. International Angiology 1991; 10: 229-32.
4. Bliss B, Wilkins D, Campbell WB et al. Treatment of limb threatening ischaemia with intravenous iloprost: a randomised double-blind, placebo-controlled study. Eur J Vasc Surg 1991; 5: 511-6.
5. Brock FE, Abri O, Baitsch G et al. Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative. Schweiz Med Wochenschr 1990; 120: 1477-82.
6. Bugiardini R, Galvani M, Ferrini D et al. Myocardial ischaemia during intravenous prostacyclin administration: Hemodynamic findings and precautionary measures. Am Heart J 1987; 113: 234-40.
7. Caspary L, Creutzig A, Alexander K. Intravenous infusion of iloprost in arterial occlusive disease: Dose-dependent effects on skin microcirculation. Eur J Clin Pharmacol 1991; 41: 131-36.
8. Diehm C, Abri O, Baitsch G et al. Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study. Dtsch Med Wochenschr 1989; 114:783-8.
9. Fitscha P, Tiso B, Krais T, Sinzinger H. Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD). Adv Prostaglandin Thromboxane Leukot Res 1987; 17: 450-4.
10. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential on peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992; 43: 889-924.
11. Gruss JD. Prostanoide in der Behandlung der chronisch arteriellen Verschlußkrankheit aus gefaßchirurgischer Sicht. Hämostaseologie 1993; 13: 58-64.
12. Guilmot JL, Diot E. Treatment of lower limb ischaemia due to atherosclerosis in diabetic and nondiabetic patients with iloprost, a stable analogue of prostacyclin. Drug Invest 1991 ; 3: 351-9.
13. Krause W, Krais T. Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man. Eur J Clin Pharmacol 1986; 30: 61-8.
14. Loosemore TM, Chalmers TC, Dormandy JA. A meta-analysis of randomized placebo control trials in Fontaine stages III-IV peripheral occlusive arterial disease. International Angiology 1994; 13: 133-42.
15. Norgren L, Alwmark A, Angqvist KA et al. A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc Surg 1990; 4: 463-7.
16. Scheffler P, de la Hamette D, Leipnitz G. Therapeutic efficacy of intravenously applied prostaglandin E1. Vasa Suppl 1989; 28: 19-25.